AI assistant
Sending…
NEKTAR THERAPEUTICS — Director's Dealing 2012
Jun 28, 2012
32134_dirs_2012-06-28_9641a047-91b6-47a7-913f-b1f140dcfdda.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2012-06-27
Reporting Person: Medve Robert (Chief Medical Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-06-27 | Employee Stock Option | $8.01 | A | 150000 | Acquired | 2020-06-26 | Common Stock (150000) | Direct |
Footnotes
F1: Stock option vests on a monthly pro-rata basis over 4 years from the grant date (June 27, 2012).
More from NEKTAR THERAPEUTICS
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 5
Capital/Financing Update
2026
May 8
Annual Report
2026
Apr 24
Capital/Financing Update
2026
Apr 23
Capital/Financing Update
2026
Apr 23
Capital/Financing Update
2026
Apr 20
Regulatory Filings
2026
Apr 20
Regulatory Filings
2026
Apr 20
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 20